{"transactions":[{"id":754108,"issuer":{"id":6516,"kind":"organization","name":"Connect Biopharma Holdings Ltd"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-02T20:30:20.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":2.4774,"value":371610.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.37 to $2.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, James Huang may be deemed to share beneficial ownership of the Ordinary Shares reported herein, but disclaims such beneficial ownership."}],"balance_after":13310000,"source":{"system":"sec-edgar","filing":"0001193125-26-253607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526253607/ownership.xml","form_type":"4"}},{"id":784381,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T22:45:04.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":313446,"price":10.0975,"value":3165020.985,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.50, inclusive. The Reporting Person undertake to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Venture Healthcare Fund II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":1011000,"source":{"system":"sec-edgar","filing":"0001193125-26-217380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526217380/ownership.xml","form_type":"4"}},{"id":822543,"issuer":{"id":6516,"kind":"organization","name":"Connect Biopharma Holdings Ltd"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-01T20:30:16.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1160000,"price":3.45,"value":4002000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, James Huang may be deemed to share beneficial ownership of the Ordinary Shares reported herein, but disclaims such beneficial ownership."}],"balance_after":13160000,"source":{"system":"sec-edgar","filing":"0001193125-26-138012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526138012/ownership.xml","form_type":"4"}},{"id":833171,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-03-19T20:30:10.000Z","date":"2026-03-17","kind":"exercise","planned":false,"acquired":false,"shares":259163,"price":6.6099,"value":1713041.5137,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrants are immediately exercisable and do not expire. Pursuant to the terms of the warrants, no portion of the warrants held by a holder may be exercised to the extent that, after giving effect to the attempted exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of the Issuer's common stock would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of the outstanding common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants are immediately exercisable and do not expire. Pursuant to the terms of the warrants, no portion of the warrants held by a holder may be exercised to the extent that, after giving effect to the attempted exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of the Issuer's common stock would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of the outstanding common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":259163},"source":{"system":"sec-edgar","filing":"0001193125-26-116060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526116060/ownership.xml","form_type":"4"}},{"id":833170,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-19T20:30:10.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":5,"price":5.23,"value":26.15,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":307894,"source":{"system":"sec-edgar","filing":"0001193125-26-116060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526116060/ownership.xml","form_type":"4"}},{"id":833169,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-19T20:30:10.000Z","date":"2026-03-17","kind":"exercise","planned":false,"acquired":true,"shares":259163,"price":0.0001,"value":25.9163,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":307899,"source":{"system":"sec-edgar","filing":"0001193125-26-116060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526116060/ownership.xml","form_type":"4"}},{"id":939081,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T02:16:25.000Z","date":"2026-01-12","kind":"sale","planned":false,"acquired":false,"shares":80554,"price":6.0707,"value":489019.1678,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.9888 to $6.2838, inclusive. The Reporting Person undertake to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":1324446,"source":{"system":"sec-edgar","filing":"0001193125-26-013358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312526013358/ownership.xml","form_type":"4"}},{"id":984839,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-12-01T22:00:04.000Z","date":"2025-11-28","kind":"exercise","planned":false,"acquired":false,"shares":48737,"price":6.6099,"value":322146.6963,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrants are immediately exercisable and do not expire. Pursuant to the terms of the warrants, no portion of the warrants held by a holder may be exercised to the extent that, after giving effect to the attempted exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of the Issuer's common stock would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of the outstanding common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants are immediately exercisable and do not expire. Pursuant to the terms of the warrants, no portion of the warrants held by a holder may be exercised to the extent that, after giving effect to the attempted exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of the Issuer's common stock would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of the outstanding common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The warrants are immediately exercisable and do not expire. Pursuant to the terms of the warrants, no portion of the warrants held by a holder may be exercised to the extent that, after giving effect to the attempted exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of the Issuer's common stock would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of the outstanding common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":259163,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":48737},"source":{"system":"sec-edgar","filing":"0001193125-25-304018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312525304018/ownership.xml","form_type":"4"}},{"id":984838,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:00:04.000Z","date":"2025-11-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1,"price":14.03,"value":14.03,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":48736,"source":{"system":"sec-edgar","filing":"0001193125-25-304018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312525304018/ownership.xml","form_type":"4"}},{"id":984837,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:00:04.000Z","date":"2025-11-28","kind":"exercise","planned":false,"acquired":true,"shares":48737,"price":0.0001,"value":4.8737,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":48737,"source":{"system":"sec-edgar","filing":"0001193125-25-304018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000119312525304018/ownership.xml","form_type":"4"}},{"id":1061285,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T00:15:04.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":true,"shares":55000,"price":12.1895,"value":670422.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.83 to $12.44, inclusive. The Reporting Person undertake to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Venture Healthcare Fund II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":1405000,"source":{"system":"sec-edgar","filing":"0000950170-25-110310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000095017025110310/ownership.xml","form_type":"4"}},{"id":1083922,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":48282,"kind":"organization","name":"Panacea Innovation Ltd","position":1,"cik":"0002010692","reported_name":"Panacea Innovation Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T13:00:05.000Z","date":"2025-07-17","kind":"purchase","planned":false,"acquired":true,"shares":19335,"price":9.6391,"value":186371.9985,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. (\"Fund II GP\") and Panacea Opportunity Fund I GP Company, Ltd. (\"Opportunity Fund GP\"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership."}],"balance_after":1350000,"source":{"system":"sec-edgar","filing":"0000950170-25-097087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000095017025097087/ownership.xml","form_type":"4"}},{"id":1862805,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option\n(right to buy)","published_at":"2023-06-08T21:22:59.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014916/doc4.xml","form_type":"4"}},{"id":1886460,"issuer":{"id":113330,"kind":"organization","name":"Orion Biotech Opportunities Corp.","symbol":"ORIA"},"owners":[{"id":113338,"kind":"organization","name":"Orion Sponsor Holdings, LLC","position":1,"cik":"0001847414","reported_name":"Orion Sponsor Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42283,"kind":"person","name":"Huang James","position":2,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B ordinary shares","published_at":"2023-05-18T20:05:13.000Z","date":"2023-05-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4879999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by Orion Sponsor Holdings, LLC (the \"Sponsor\") were surrendered for no compensation on May 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by Orion Sponsor Holdings, LLC (the \"Sponsor\") were surrendered for no compensation on May 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by Orion Sponsor Holdings, LLC (the \"Sponsor\") were surrendered for no compensation on May 17, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by Orion Sponsor Holdings, LLC (the \"Sponsor\") were surrendered for no compensation on May 17, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed by the Sponsor. The Class B ordinary shares are held in the name of the Sponsor. The Sponsor is managed by a board of managers comprised of James Huang, John Phelan and Robert Platek, who control the Sponsor. Accordingly, Messrs. Huang, Phelan and Platek have voting and investment discretion with respect to the securities held by the Sponsor, and may be deemed to have beneficial ownership of the securities held directly by the Sponsor. Each of Messrs. Huang, Phelan and Platek disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":1,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":4879999},"source":{"system":"sec-edgar","filing":"0001213900-23-041169","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573160/000121390023041169/ownership.xml","form_type":"4"}},{"id":1996950,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":2224616,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":2224616,"derivative":{"exercise_price":0.2152,"exercise_date":"2023-08-21","expiration_date":"2028-08-21","underlying":"Common Stock","underlying_shares":2224616},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996949,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"other","acquired":false,"shares":1112308,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.1411,"exercise_date":"2023-02-22","expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":1112308},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996948,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":1112308,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":1112308,"derivative":{"exercise_price":0.1411,"exercise_date":"2023-02-22","expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":1112308},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996947,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":12,"exercise_date":"2019-01-02","expiration_date":"2023-07-02","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996946,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":498008,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":12.15,"exercise_date":"2018-12-24","expiration_date":"2023-12-24","underlying":"Common Stock","underlying_shares":498008},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996945,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":275938,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":12.09,"exercise_date":"2020-06-06","expiration_date":"2024-12-06","underlying":"Common Stock","underlying_shares":275938},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996944,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":275862,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":7.975,"exercise_date":"2020-05-22","expiration_date":"2025-05-22","underlying":"Common Stock","underlying_shares":275862},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996943,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"other","acquired":true,"shares":1112308,"price":0.1411,"value":156946.6588,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":3449161,"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":2163552,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T18:51:39.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":33300,"price":4.2831,"value":142627.23,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.115 to $4.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":371517,"source":{"system":"sec-edgar","filing":"0000899243-22-030690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322030690/doc4.xml","form_type":"4"}},{"id":2163551,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T18:51:39.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":3111,"price":3.9965,"value":12433.1115,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.9401 to $4.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":338217,"source":{"system":"sec-edgar","filing":"0000899243-22-030690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322030690/doc4.xml","form_type":"4"}},{"id":2163550,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T18:51:39.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":19162,"price":3.8932,"value":74601.4984,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":335106,"source":{"system":"sec-edgar","filing":"0000899243-22-030690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322030690/doc4.xml","form_type":"4"}},{"id":2168207,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-02T19:35:18.000Z","date":"2022-09-02","kind":"purchase","acquired":true,"shares":400,"price":3.7413,"value":1496.52,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":315944,"source":{"system":"sec-edgar","filing":"0000899243-22-030336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322030336/doc4.xml","form_type":"4"}},{"id":2168206,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-02T19:35:18.000Z","date":"2022-09-01","kind":"purchase","acquired":true,"shares":11821,"price":3.7229,"value":44008.4009,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.71 to $3.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":315544,"source":{"system":"sec-edgar","filing":"0000899243-22-030336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322030336/doc4.xml","form_type":"4"}},{"id":2168205,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-02T19:35:18.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":24975,"price":3.745,"value":93531.375,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.69 to $3.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":303723,"source":{"system":"sec-edgar","filing":"0000899243-22-030336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322030336/doc4.xml","form_type":"4"}},{"id":2173340,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T20:48:27.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":39527,"price":3.7488,"value":148178.8176,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":278748,"source":{"system":"sec-edgar","filing":"0000899243-22-029897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322029897/doc4.xml","form_type":"4"}},{"id":2173339,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T20:48:27.000Z","date":"2022-08-24","kind":"purchase","acquired":true,"shares":5000,"price":3.7502,"value":18751.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":239221,"source":{"system":"sec-edgar","filing":"0000899243-22-029897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322029897/doc4.xml","form_type":"4"}},{"id":2176490,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T20:19:16.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":40000,"price":3.4998,"value":139992.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.46 to $3.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":234221,"source":{"system":"sec-edgar","filing":"0000899243-22-029564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322029564/doc4.xml","form_type":"4"}},{"id":2176489,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T20:19:16.000Z","date":"2022-08-22","kind":"purchase","acquired":true,"shares":23105,"price":3.4641,"value":80038.0305,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":194221,"source":{"system":"sec-edgar","filing":"0000899243-22-029564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322029564/doc4.xml","form_type":"4"}},{"id":2176488,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T20:19:16.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":171116,"price":3.2694,"value":559446.6504,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.075 to $3.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":171116,"source":{"system":"sec-edgar","filing":"0000899243-22-029564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000089924322029564/doc4.xml","form_type":"4"}},{"id":2222286,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:35:24.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-024006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024006/doc4.xml","form_type":"4"}},{"id":2222285,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:35:24.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188333,"source":{"system":"sec-edgar","filing":"0000899243-22-024006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024006/doc4.xml","form_type":"4"}},{"id":2222280,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:31:53.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023988/doc4.xml","form_type":"4"}},{"id":2222279,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:31:53.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188333,"source":{"system":"sec-edgar","filing":"0000899243-22-023988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023988/doc4.xml","form_type":"4"}},{"id":2238209,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T00:16:06.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":0.47,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-22-014716","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014716/rdgdoc.xml","form_type":"4"}},{"id":2238208,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-10T00:16:06.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":296281,"source":{"system":"sec-edgar","filing":"0001437749-22-014716","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014716/rdgdoc.xml","form_type":"4"}},{"id":2255981,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T16:23:13.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":397419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":397419,"derivative":{"exercise_price":0.4664,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":397419},"source":{"system":"sec-edgar","filing":"0001104659-22-065283","document":"tm2214966d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000110465922065283/tm2214966d1_4seq1.xml","form_type":"4"}},{"id":2539854,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:56:06.000Z","date":"2021-10-19","kind":"purchase","acquired":true,"shares":50000,"price":1.9027,"value":95135.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $1.84 to $1.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":291281,"source":{"system":"sec-edgar","filing":"0001437749-21-023912","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921023912/rdgdoc.xml","form_type":"4"}},{"id":2579934,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-03T21:21:03.000Z","date":"2021-09-01","kind":"purchase","acquired":true,"shares":100000,"price":1.71,"value":171000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":108333,"source":{"system":"sec-edgar","filing":"0001209191-21-054824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121054824/doc4.xml","form_type":"4"}},{"id":2664802,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-18T00:03:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.28,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-015119","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921015119/rdgdoc.xml","form_type":"4"}},{"id":2667066,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T16:01:42.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":113028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":113028,"derivative":{"exercise_price":1.65,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":113028},"source":{"system":"sec-edgar","filing":"0001104659-21-081985","document":"tm2119809d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000110465921081985/tm2119809d2_4.xml","form_type":"4"}},{"id":2725341,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-06T23:22:33.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying this option will vest on 4/4/2021, 5/4/2021 and 5/19/2021."}],"balance_after":62500,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-21-030740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030740/doc4.xml","form_type":"4"}},{"id":2725340,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-06T23:22:33.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares will vest on 5/19/2021."}],"balance_after":8333,"source":{"system":"sec-edgar","filing":"0001209191-21-030740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030740/doc4.xml","form_type":"4"}},{"id":2762460,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-04-02T21:13:54.000Z","date":"2021-03-31","kind":"purchase","acquired":true,"shares":150000,"price":2.36,"value":354000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $2.275 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171000,"source":{"system":"sec-edgar","filing":"0001437749-21-008134","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008134/rdgdoc.xml","form_type":"4"}},{"id":2877805,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-06T02:13:13.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"exercise_date":"2021-02-03","expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-002148","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921002148/rdgdoc.xml","form_type":"4"}},{"id":2999505,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-10-27T10:02:38.000Z","date":"2020-10-23","kind":"purchase","acquired":true,"shares":1000,"price":6.666,"value":6666.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $6.66 to $6.67. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001437749-20-021666","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920021666/rdgdoc.xml","form_type":"4"}},{"id":3000157,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-10-26T22:26:21.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":12000,"price":7.3223,"value":87867.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $7.09 to $7.58. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-20-021655","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920021655/rdgdoc.xml","form_type":"4/A","original_submission_date":"2020-06-05"}},{"id":3078060,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-22T21:03:20.000Z","date":"2020-07-20","kind":"grant","acquired":true,"shares":119178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest on July 20, 2022."}],"balance_after":119178,"derivative":{"exercise_price":3.43,"expiration_date":"2030-07-20","underlying":"Common Stock","underlying_shares":119178},"source":{"system":"sec-edgar","filing":"0001209191-20-043323","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120043323/doc4.xml","form_type":"4"}},{"id":3105973,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T06:05:20.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":70400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":70400,"derivative":{"exercise_price":2.63,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":70400},"source":{"system":"sec-edgar","filing":"0001104659-20-074356","document":"tm2022841d4_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000110465920074356/tm2022841d4_form4.xml","form_type":"4"}},{"id":3121041,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-06-06T00:36:39.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":12200,"price":7.3223,"value":89332.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $7.09 to $7.58. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20200,"source":{"system":"sec-edgar","filing":"0001437749-20-012549","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920012549/rdgdoc.xml","form_type":"4"}},{"id":3121040,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-06-06T00:36:39.000Z","date":"2020-06-03","kind":"purchase","acquired":true,"shares":200,"price":7.4199,"value":1483.98,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001437749-20-012549","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920012549/rdgdoc.xml","form_type":"4"}},{"id":3134285,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock Warrants","published_at":"2020-05-28T01:37:59.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":275862,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Via Panacea Venture Healthcare Fund I L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above."}],"balance_after":275862,"derivative":{"exercise_price":7.975,"exercise_date":"2020-05-22","expiration_date":"2025-05-22","underlying":"Common Stock","underlying_shares":275862},"source":{"system":"sec-edgar","filing":"0001437749-20-011868","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011868/rdgdoc.xml","form_type":"4"}},{"id":3134284,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-05-28T01:37:59.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":275862,"price":7.25,"value":1999999.5,"ownership":{"direct":false,"nature":"Via Panacea Venture Healthcare Fund I L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P.  The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein."}],"balance_after":2336853,"source":{"system":"sec-edgar","filing":"0001437749-20-011868","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011868/rdgdoc.xml","form_type":"4"}},{"id":3260579,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-02-20T21:21:02.000Z","date":"2020-02-18","kind":"purchase","acquired":true,"shares":400,"price":3.8375,"value":1535.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $3.75 to $4.10. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001437749-20-003165","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920003165/rdgdoc.xml","form_type":"4"}},{"id":3285194,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-02-07T22:11:53.000Z","date":"2020-02-07","kind":"purchase","acquired":true,"shares":500,"price":4.05,"value":2025.0,"ownership":{"direct":true},"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001437749-20-002069","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920002069/rdgdoc.xml","form_type":"4"}},{"id":3306740,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-01-22T01:52:25.000Z","date":"2020-01-17","kind":"purchase","acquired":true,"shares":2000,"price":4.1829,"value":8365.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $4.10 to $4.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001437749-20-000944","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920000944/rdgdoc.xml","form_type":"4"}},{"id":3306739,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-01-22T01:52:25.000Z","date":"2020-01-16","kind":"purchase","acquired":true,"shares":58,"price":4.2,"value":243.6,"ownership":{"direct":true},"balance_after":20500,"source":{"system":"sec-edgar","filing":"0001437749-20-000944","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920000944/rdgdoc.xml","form_type":"4"}},{"id":3324464,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-01-03T21:41:48.000Z","date":"2019-12-31","kind":"purchase","acquired":true,"shares":15442,"price":4.049,"value":62524.658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $3.81 to $4.99. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20442,"source":{"system":"sec-edgar","filing":"0001437749-20-000169","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920000169/rdgdoc.xml","form_type":"4"}},{"id":3329248,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-12-31T21:08:14.000Z","date":"2019-12-30","kind":"purchase","acquired":true,"shares":909,"price":3.81,"value":3463.29,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001437749-19-025048","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919025048/rdgdoc.xml","form_type":"4"}},{"id":3329247,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-12-31T21:08:14.000Z","date":"2019-12-27","kind":"purchase","acquired":true,"shares":4091,"price":3.7303,"value":15260.6573,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $3.55 to $4.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4091,"source":{"system":"sec-edgar","filing":"0001437749-19-025048","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919025048/rdgdoc.xml","form_type":"4"}},{"id":3347175,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series I Warrants","published_at":"2019-12-10T21:36:01.000Z","date":"2019-12-06","kind":"purchase","acquired":true,"shares":827815,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Via Panacea Venture  Healthcare Fund I L.P"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Issued in connection with the purchase of shares of common stock on December 6, 2019 as reported above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is Director of Panacea Venture Healthcare Fund GP I L.P.  The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein."}],"balance_after":827815,"derivative":{"exercise_price":4.03,"exercise_date":"2020-06-06","expiration_date":"2024-12-06","underlying":"Common Stock","underlying_shares":827815},"source":{"system":"sec-edgar","filing":"0001437749-19-024141","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919024141/rdgdoc.xml","form_type":"4"}},{"id":3347174,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-12-10T21:36:01.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":96429,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Via Rui Jin (HK) Consulting Management Company Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Issued in connection with a Placement Agency Agreement for the Company's offering of common stock and warrants on December 6, 2019.  The Reporting Person is a Director of Rui Jin (HK) Consulting Management Company Limited."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with a Placement Agency Agreement for the Company's offering of common stock and warrants on December 6, 2019.  The Reporting Person is a Director of Rui Jin (HK) Consulting Management Company Limited."}],"balance_after":210844,"source":{"system":"sec-edgar","filing":"0001437749-19-024141","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919024141/rdgdoc.xml","form_type":"4"}},{"id":3347173,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-12-10T21:36:01.000Z","date":"2019-12-06","kind":"purchase","acquired":true,"shares":1655629,"price":3.02,"value":4999999.58,"ownership":{"direct":false,"nature":"Via Panacea Venture Healthcare Fund I L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is Director of Panacea Venture Healthcare Fund GP I L.P.  The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein."}],"balance_after":6182974,"source":{"system":"sec-edgar","filing":"0001437749-19-024141","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919024141/rdgdoc.xml","form_type":"4"}},{"id":3481835,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T17:01:22.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":59231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":59231,"derivative":{"exercise_price":3.13,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":59231},"source":{"system":"sec-edgar","filing":"0001144204-19-031916","document":"tv524054_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420419031916/tv524054_4.xml","form_type":"4"}},{"id":3547988,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-04-26T21:35:26.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in a series of three successive, equal installments measured from the date of Mr. Huang's appointment to the Board of Directors on December 21, 2018."}],"balance_after":60000,"derivative":{"exercise_price":4.32,"exercise_date":"2019-12-21","expiration_date":"2029-04-24","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-19-008084","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919008084/rdgdoc.xml","form_type":"4"}},{"id":3876927,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2018-07-03T15:38:37.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of one year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of one year."}],"balance_after":50000,"derivative":{"exercise_price":8.23,"expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-18-037214","document":"tv497981_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420418037214/tv497981_4.xml","form_type":"4"}},{"id":3967971,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-06T17:33:28.000Z","date":"2018-04-04","kind":"other","acquired":true,"shares":191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Like-kind distribution of shares by KPCB China Fund II, LP (\"KPCB\") to its limited partners. The general partner of KPCB is KPCB China Associates II, L.P. (\"Associates \"). The general partner of Associates is KPCB China Holdings II, Ltd., of which the Reporting Person is a director. The Reporting Person received 191 shares as a result of his interest in KPCB."}],"balance_after":191,"source":{"system":"sec-edgar","filing":"0001144204-18-019667","document":"tv490551_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420418019667/tv490551_4.xml","form_type":"4"}},{"id":3967970,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-06T17:33:28.000Z","date":"2018-04-04","kind":"other","acquired":false,"shares":416666,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Like-kind distribution of shares by KPCB China Fund II, LP (\"KPCB\") to its limited partners. The general partner of KPCB is KPCB China Associates II, L.P. (\"Associates \"). The general partner of Associates is KPCB China Holdings II, Ltd., of which the Reporting Person is a director. The Reporting Person received 191 shares as a result of his interest in KPCB."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Like-kind distribution of shares by KPCB China Fund II, LP (\"KPCB\") to its limited partners. The general partner of KPCB is KPCB China Associates II, L.P. (\"Associates \"). The general partner of Associates is KPCB China Holdings II, Ltd., of which the Reporting Person is a director. The Reporting Person received 191 shares as a result of his interest in KPCB."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-019667","document":"tv490551_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420418019667/tv490551_4.xml","form_type":"4"}},{"id":4287626,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-09T17:05:52.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of one year."}],"balance_after":50000,"derivative":{"exercise_price":1.0064,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-17-031982","document":"v468783_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420417031982/v468783_4.xml","form_type":"4"}}]}